Geneos Wealth Management Inc. Sells 1,368 Shares of Synopsys, Inc. $SNPS

Geneos Wealth Management Inc. lowered its position in Synopsys, Inc. (NASDAQ:SNPS) by 96.1% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 55 shares of the semiconductor company’s stock after selling 1,368 shares during the period. Geneos Wealth Management Inc.’s holdings in Synopsys were worth $27,000 at the end of the most recent quarter.

Other institutional investors have also bought and sold shares of the company. Vanguard Group Inc. grew its position in shares of Synopsys by 1.6% during the second quarter. Vanguard Group Inc. now owns 15,060,784 shares of the semiconductor company’s stock worth $7,721,363,000 after purchasing an additional 231,014 shares in the last quarter. State Street Corp grew its holdings in Synopsys by 1.2% during the 2nd quarter. State Street Corp now owns 7,266,446 shares of the semiconductor company’s stock valued at $3,725,362,000 after buying an additional 85,662 shares in the last quarter. Geode Capital Management LLC raised its position in shares of Synopsys by 1.5% during the second quarter. Geode Capital Management LLC now owns 3,545,892 shares of the semiconductor company’s stock valued at $1,810,214,000 after buying an additional 51,043 shares during the last quarter. Ameriprise Financial Inc. raised its position in shares of Synopsys by 29.1% during the second quarter. Ameriprise Financial Inc. now owns 2,598,874 shares of the semiconductor company’s stock valued at $1,333,095,000 after buying an additional 585,494 shares during the last quarter. Finally, Alliancebernstein L.P. lifted its holdings in shares of Synopsys by 10.9% in the second quarter. Alliancebernstein L.P. now owns 1,913,001 shares of the semiconductor company’s stock worth $980,757,000 after buying an additional 187,790 shares in the last quarter. Hedge funds and other institutional investors own 85.47% of the company’s stock.

Analyst Ratings Changes

Several research analysts have commented on SNPS shares. Bank of America raised shares of Synopsys from an “underperform” rating to a “neutral” rating and dropped their price objective for the company from $525.00 to $500.00 in a report on Monday, December 8th. Wells Fargo & Company raised their price target on Synopsys from $445.00 to $500.00 and gave the company an “equal weight” rating in a report on Thursday, December 11th. Zacks Research raised Synopsys from a “strong sell” rating to a “hold” rating in a research note on Monday, November 10th. Needham & Company LLC increased their target price on Synopsys from $550.00 to $580.00 and gave the company a “buy” rating in a research report on Thursday, December 11th. Finally, Morgan Stanley raised their target price on shares of Synopsys from $510.00 to $550.00 and gave the company an “overweight” rating in a report on Friday, December 12th. Nine equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $553.57.

Insider Activity

In related news, CFO Shelagh Glaser sold 3,657 shares of the stock in a transaction dated Friday, December 19th. The shares were sold at an average price of $460.77, for a total value of $1,685,035.89. Following the sale, the chief financial officer directly owned 17,842 shares of the company’s stock, valued at $8,221,058.34. This represents a 17.01% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Janet Lee sold 250 shares of the firm’s stock in a transaction dated Monday, January 12th. The stock was sold at an average price of $530.00, for a total transaction of $132,500.00. Following the completion of the sale, the insider directly owned 11,959 shares of the company’s stock, valued at approximately $6,338,270. The trade was a 2.05% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 4,157 shares of company stock worth $1,945,036 over the last quarter. 0.62% of the stock is currently owned by insiders.

Key Synopsys News

Here are the key news stories impacting Synopsys this week:

• Positive Sentiment: Synopsys entered a definitive agreement to sell its ARC Processor IP Solutions business to GlobalFoundries, which Synopsys frames as a portfolio-sharpening move to focus on higher‑value interface and foundation IP and AI-driven opportunities — a potential long-term positive for margin and capital allocation. Synopsys Enters Definitive Agreement with GlobalFoundries For Sale of Processor IP Solutions Business
• Neutral Sentiment: GlobalFoundries confirmed the acquisition and said it will combine ARC with MIPS to accelerate physical-AI and custom silicon offerings; transaction expected to close in H2 2026 and remains subject to regulatory approvals — strategic for the industry but not immediately accretive until close. GlobalFoundries Announces Acquisition of Synopsys’ ARC Processor IP Solutions Business to Enhance Custom Silicon and AI Capabilities
• Neutral Sentiment: Increased retail/institutional attention: Zacks flagged SNPS as one of the most-searched stocks recently — a sign of elevated interest/volatility but not a directional catalyst by itself. Investors Heavily Search Synopsys, Inc. (SNPS): Here is What You Need to Know
• Negative Sentiment: Piper Sandler downgraded SNPS from overweight to neutral and trimmed its price target — an analyst-level setback that likely pressured sentiment and can trigger short‑term selling. Piper Sandler downgrades Synopsys (SNPS)
• Negative Sentiment: Insider selling: Synopsys’ General Counsel Janet Lee sold 250 shares recently (disclosed filings show a series of small sales). While the amounts are modest, visible insider sales can amplify near-term selling pressure when combined with other negative news. Top Synopsys Insider Makes Notable Move With Fresh Stock Sale
• Negative Sentiment: Shareholder lawsuit notice: A plaintiffs’ notice for investors who bought SNPS before Dec 2024 introduces legal overhang and potential liability or distraction, which can be a sentiment drag until resolved. LONG TERM Investors in shares of Synopsys Inc should contact the Shareholders Foundation in connection with Lawsuit

Synopsys Price Performance

NASDAQ:SNPS opened at $505.34 on Thursday. The firm has a market capitalization of $96.68 billion, a price-to-earnings ratio of 63.25, a PEG ratio of 4.26 and a beta of 1.12. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.62 and a quick ratio of 1.52. The business has a 50 day simple moving average of $450.65 and a 200-day simple moving average of $505.02. Synopsys, Inc. has a 1 year low of $365.74 and a 1 year high of $651.73.

Synopsys (NASDAQ:SNPS) last issued its quarterly earnings results on Wednesday, December 10th. The semiconductor company reported $2.90 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.79 by $0.11. The company had revenue of $2.25 billion during the quarter, compared to the consensus estimate of $2.25 billion. Synopsys had a return on equity of 7.89% and a net margin of 18.89%.Synopsys’s revenue was up 37.8% on a year-over-year basis. During the same period last year, the company earned $3.40 earnings per share. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. Equities analysts forecast that Synopsys, Inc. will post 10.64 EPS for the current year.

About Synopsys

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.